⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1304516 | 0.90 | — | — | |
| SCHEMBL7775509 | 0.63 | — | — | |
| SCHEMBL19953010 | 0.62 | — | — | |
| SCHEMBL578562 | 0.62 | — | — | |
| SCHEMBL342704 | 0.62 | — | — | |
| SCHEMBL5442741 | 0.62 | — | — | |
| SCHEMBL1822042 | 0.62 | — | — | |
| SCHEMBL1023608 | 0.61 | — | — | |
| SCHEMBL9128888 | 0.61 | — | — | |
| SCHEMBL9125944 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118271238-A | 2-Cyanoacrylamides derivatives and use thereof | 四川大学 | 2024-07-02 | — | — | CN | claimed |
| WO-2024046937-A1 | THREOSE NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDES AND METHODS THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2024-03-07 | — | — | WO | claimed |
| EP-4332221-A1 | THREOSE NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDES AND METHODS THEREOF | Roche Innovation Center Copenhagen A/S (DK) | 2024-03-06 | — | — | EP | claimed |
| WO-2023117738-A1 | THREOSE NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDES AND METHODS THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2023-06-29 | — | — | WO | claimed |
| CN-114729355-A | PPM1A inhibitors and methods of using the same | 奎里斯公司 | 2022-07-08 | — | — | CN | claimed |
| CN-113631709-A | Compositions and methods for treating KCNT 1-related disorders | 普拉克西斯精密药物股份有限公司 | 2021-11-09 | — | — | CN | claimed |
| CN-110225895-B | Base protective film, adhesion preventing member, and method for forming adhesion preventing member | 星和电机株式会社 | 2021-11-02 | — | — | CN | claimed |
| CN-110225895-A | Matrix protective film, attachment prevent component and attachment from preventing the forming method of component | 星和电机株式会社 | 2019-09-10 | — | — | CN | claimed |
| CN-118271238-A | 2-Cyanoacrylamides derivatives and use thereof | 四川大学 | 2024-07-02 | — | — | CN | disclosed |
| WO-2024046937-A1 | THREOSE NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDES AND METHODS THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2024-03-07 | — | — | WO | disclosed |
| EP-4332221-A1 | THREOSE NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDES AND METHODS THEREOF | Roche Innovation Center Copenhagen A/S (DK) | 2024-03-06 | — | — | EP | disclosed |
| CN-117143121-A | Compounds and uses thereof | 华为技术有限公司 | 2023-12-01 | — | — | CN | disclosed |
| US-20230299354-A1 | ELECTROLYTE, AND ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS CONTAINING SAME | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2023-09-21 | — | — | US | disclosed |
| EP-4246641-A1 | ELECTROLYTE, AS WELL AS ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS CONTAINING THE SAME | Ningde Amperex Technology Ltd. (CN) | 2023-09-20 | — | — | EP | disclosed |
| US-5234946-A | Anticholesterol, antilipemic | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-08-10 | — | — | US | disclosed |
| EP-0318860-B1 | SUBSTITUTED ALKYLAMINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-06-16 | — | — | EP | disclosed |
| CN-1037141-A | The alkylamine derivative that replaces | BANYU PHARMA CO LTD (JP) | 1989-11-15 | — | — | CN | disclosed |
| EP-0318860-A2 | Substituted alkylamine derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-06-07 | — | — | EP | disclosed |
| US-4792618-A | CHEMICAL INTERMEDIATE FOR POLYMERS AND PESTICIDES | OCCIDENTAL CHEMICAL CORPORATION (US) | 1988-12-20 | — | — | US | disclosed |
| US-4792618-A | CHEMICAL INTERMEDIATE FOR POLYMERS AND PESTICIDES | OCCIDENTAL CHEMICAL CORPORATION (US) | 1988-12-20 | — | — | US | disclosed |